Search for: "ORTHO-MCNEIL V MYLAN LABS"
Results 1 - 20
of 40
Sorted by Relevance
|
Sort by Date
11 Apr 2008, 8:48 am
Ortho-Mcneil Pharmaceutical v. [read post]
15 Feb 2007, 8:26 am
Ortho-McNeil Pharma. v. [read post]
1 Apr 2008, 9:15 am
Ortho-McNeil Pharmaceutical v. [read post]
10 Jun 2009, 9:30 pm
Ortho-McNeil Pharm., Inc. v. [read post]
16 Jun 2009, 9:31 am
Ortho-McNeil Pharma v. [read post]
27 Oct 2006, 9:43 am
In Ortho-McNeil Pharmaceutical v. [read post]
21 Apr 2014, 7:57 pm
”Ortho-McNeil Pharm., Inc. v. [read post]
6 Aug 2007, 8:38 pm
Apotex; Ortho-McNeil v. [read post]
2 Apr 2007, 9:52 pm
Eon Topamax: Ortho-McNeil v. [read post]
8 Apr 2008, 3:27 pm
More detail of Ortho-McNeil Pharm., Inc. v. [read post]
17 Jun 2009, 3:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Gene patenting debate continues: UCLA v USPTO (Patent Docs) (Patent Docs) (PatentlyBIOtech) (Patent Docs) (IP Watchdog) US: FTC issues highly anticipated report on follow-on biologics; report concludes that special legislative exclusivity incentives are largely unwarranted for innovators and generics (FDA Law Blog) (Patent Docs)… [read post]
17 Jun 2009, 3:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Gene patenting debate continues: UCLA v USPTO (Patent Docs) (Patent Docs) (PatentlyBIOtech) (Patent Docs) (IP Watchdog) US: FTC issues highly anticipated report on follow-on biologics; report concludes that special legislative exclusivity incentives are largely unwarranted for innovators and generics (FDA Law Blog) (Patent Docs) (Patent… [read post]
14 Nov 2012, 1:51 pm
See Ortho-McNeil Pharm., Inc. v. [read post]
2 Mar 2010, 5:10 am
Cir. 2007); see also Ortho-McNeil Pharm., Inc. v. [read post]
27 Aug 2011, 7:55 pm
Ortho-McNeil Pharm., Inc. [read post]
7 Nov 2008, 3:42 am
Sandoz, Inc (Patent Docs) (PATracer) Boniva (Ibandronic acid) – US: Hoffman La Roche files third patent infringement lawsuit against Orchid over generic Boniva (GenericsWeb) Carbatrol (Carbamazepine) – US: Federal Judge grants summary judgment of noninfringement to Corepharma in Carbatrol patent dispute with Shire Laboratories (Law360) Effexor (Venlafaxine) – US: Wyeth settles with fourth drug company, Anchen Pharmaceuticals, over generic Effexor (Law360) Fentora… [read post]
9 Sep 2010, 7:09 pm
See Ortho-McNeil Pharm., Inc. v. [read post]
3 May 2010, 5:08 pm
” Ortho-McNeil Pharm., Inc. v. [read post]
2 Sep 2010, 10:51 am
Ortho-McNeil Pharmaceutical, Inc. v. [read post]
3 Mar 2010, 5:05 am
‘The solution lies in resources’ says FDA Commissioner Hamburg (FDA Law Blog) Products Actoplus MET (Pioglitazone) – US: Takeda files patent infringement suit against Aurobindo following Para IV certification as part of ANDA to manufacture generic Actoplus MET (Patent Docs) Advair diskus (Fluticasone, Salmeterol) – US: PTO denies PTE for Advair diskus patent; Office again clarifies that PTEs are not availabile for ‘synergistic combinations’ containing… [read post]
